The Council for Scientific and Industrial Research (CSIR) has launched the country’s first anti-diabetic ayurvedic drug named BGR-34 for type two Diabetes mellitus.
BGR-34 stands for Blood Glucost Regulator and offers effective, safe, patient-friendly solution for managing type two Diabetes.
About BGR-34
The drug has been jointly developed by National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP) and CSIR institutes based in Lucknow.
It contains 34 identified active phyto-constitutes from herbal resources and works by controlling blood sugar and limiting the harmful effects of other modern drugs.
For the purpose of quality commercial production and extended distribution of this drug, CSIR has transferred the rights and technical details to AIMIL Pharmaceuticals (I) Ltds.
Current Affairs 3rd February, 2016 Current Affairs Question and Answers Round Up January. Current Affairs Round up January, 2016.
Join The Discussion